Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Clean Vision (CLNV) Cash & Equivalents (2023 - 2025)

Clean Vision (CLNV) has disclosed Cash & Equivalents for 3 consecutive years, with $3.5 million as the latest value for Q2 2025.

  • Quarterly Cash & Equivalents rose 5352.74% to $3.5 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 million through Jun 2025, up 5352.74% year-over-year, with the annual reading at $1.3 million for FY2024, 283.16% up from the prior year.
  • Cash & Equivalents for Q2 2025 was $3.5 million at Clean Vision, up from $1.3 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $3.5 million in Q2 2025, with the low at $4180.0 in Q3 2024.
  • Average Cash & Equivalents over 3 years is $839490.4, with a median of $350962.0 recorded in 2023.
  • The sharpest move saw Cash & Equivalents crashed 99.68% in 2024, then skyrocketed 5352.74% in 2025.
  • Over 3 years, Cash & Equivalents stood at $339921.0 in 2023, then soared by 283.16% to $1.3 million in 2024, then skyrocketed by 169.84% to $3.5 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $3.5 million, $1.3 million, and $4180.0 for Q2 2025, Q4 2024, and Q3 2024 respectively.